EU Commission May Not Be
Renewing Vaccine Contracts With, AstraZeneca and
Johnson & Johnson.
The EU Commission has reportedly decided to move away
from AstraZeneca and Johnson & Johnson’s COVID-19 vaccines.
An inside source told 'La Stampa,' an Italian daily
newspaper, that the commission has allegedly decided
not to renew its contracts with the companies.
The decision was reportedly made in agreement
with “leaders of many (EU) countries.”.
The European Commission, in agreement
with the leaders of many (EU) countries,
has decided that the contracts with the
companies that produce (viral vector) vaccines
that are valid for the current year will not
be renewed at their expiry. , 'La Stampa,' via WHBL.
When asked to confirm the report,
a spokesman for the EU Commission said they
could not “comment on contractual issues.” .
On Wednesday, EU Commission
President Ursula von der Leyen
separately confirmed the EU
was continuing its relationship
with Pfizer and BioNTech. .
Leyen said the EU would be negotiating
a massive contract extension through 2023 that
would see the purchase of 1.8 billion doses.
We need to focus on technologies that
have proven their worth … [Pfizer-BioNTech]
has proven to be a reliable partner. It has
delivered on its commitments, and it is
responsive to our needs. This is to the
immediate benefit of EU citizens, Ursula von der Leyen, via Associated Press
